JANE STREET GROUP, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$17,000
-60.5%
21,432
-59.9%
0.00%
Q4 2021$43,000
-48.2%
53,416
-0.0%
0.00%
Q2 2021$83,000
+167.7%
53,424
+325.6%
0.00%
Q2 2020$31,000
-11.4%
12,552
+15.3%
0.00%
Q2 2019$35,00010,8870.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders